Pharma BD Deal Intelligence
A ~$19M Spanish distribution tuck-in, absorbed and never reported on again — no evidence it mattered either way
Full analysis, sources & comparables →Innogenetics NV booked an approximately €9M profit on the divestiture and announced a new Spanish subsidiary, Innogenetics Diagnostics Iberia, to sell its…
Inverness acquired Innogenetics Diagnostica Y Terapeutica from Innogenetics NV for approximately $11.8 million plus a working capital adjustment of roughly…
The IDT deal was part of a 2005 acquisition wave (Binax, Ischemia, Thermo BioStar) through which Inverness built the global rapid-diagnostics platform that…
Source summaries from our enrichment pipeline; follow links for originals.
All 5 sources with sentiment breakdown →
Inverness acquires Spanish diagnostics distributor IDT from Innogenetics NV for ~$11.8M plus $7.2M working capital adjustment.
A ~$19M Spanish distribution tuck-in, absorbed and never reported on again — no evidence it mattered either way
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Inverness Medical Innovations Inc. / Innogenetics Diagnostica y Terapeutica S.A. (IDT) (this deal) | 2005 | $19M | 45 |
| Inverness Medical Innovations Inc. / Abbott Laboratories Rapid Diagnostics (pregnancy / drug-of-abuse lines) | 2003 | $92M | 71 |
| Inverness Medical Innovations Inc. / Ischemia Technologies Inc. | 2004 | $22M | 33 |
| Inverness Medical Innovations Inc. / Thermo BioStar, Inc. | 2005 | $52M | 31 |
| Inverness Medical Innovations Inc. / Binax Inc. | 2004 | — | — |
| AstraZeneca PLC / KuDOS Pharmaceuticals Limited | 2005 | $210M | 98 |
| Yamanouchi Pharmaceutical / Fujisawa Pharmaceutical Co. Ltd. | 2005 | — | 92 |